INDIGO's Preclinical Animal Model Platform Expands Zebrafish Offering
STATE COLLEGE, Pa., Oct. 6, 2020 /PRNewswire-PRWeb/ --INDIGO Biosciences, the recognized industry leader in nuclear receptor research, has expanded their robust portfolio of in vitro animal model assays with three additional first-in-class zebrafish model systems.
- STATE COLLEGE, Pa., Oct. 6, 2020 /PRNewswire-PRWeb/ --INDIGO Biosciences, the recognized industry leader in nuclear receptor research, has expanded their robust portfolio of in vitro animal model assays with three additional first-in-class zebrafish model systems.
- "This addition gives discovery scientists the ability to make key determinations on the correct animal model for their research with an ortholog that was not previously available before entering animal trials."
- For researchers looking at nuclear receptor activity, zebrafish provide an attractive model as nearly all of the 48 human nuclear receptors are also present in the animal model.
- With animal studies required by the FDA, selecting the animal model that provides the most representative human-surrogate is critical to assessing a potential drug's likelihood of unwanted effects.